MAPT and tauopathy: These data were confirmed by a subsequent study showing that administration of the P2×7 ATP receptor antagonist GSK1482160, which inhibits EV secretion from microglia, blocked tau propagation in the P301S tauopathy mouse model (Ruan et al., 2020).